Hikma Pharmaceuticals Plc Director/PDMR Shareholding (1746F)
May 15 2017 - 9:30AM
UK Regulatory
TIDMHIK
RNS Number : 1746F
Hikma Pharmaceuticals Plc
15 May 2017
Hikma Pharmaceuticals PLC - Vesting of EIP Awards
LONDON, 15 May 2017: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards on 15 May 2015 under the 2014 Executive
Incentive Plan ("EIP") which was completed on 15 May 2017. These
awards were automatically exercised by operation of the conditional
award and vesting process. The exercise price under the EIP is
GBPnil.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------------
a) Name Said Darwazah
--- --------------------- -------------------------------------
2 Reason for the notification
--- ------------------------------------------------------------
a) Position/status Chairman and Chief Executive Officer
--- --------------------- -------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- -------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- -------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- -------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- -------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 15 May 2017
under the 2014 Executive Incentive
Plan (EIP).
--- --------------------- -------------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 41,000
--- --------------------- -------------------------------------
d) Aggregated N/A
information
--- --------------------- -------------------------------------
e) Date of the 15 May 2017
transaction
--- --------------------- -------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- -------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- -----------------------------------------------------------
a) Name Mazen Darwazah
--- --------------------- ------------------------------------
2 Reason for the notification
--- -----------------------------------------------------------
a) Position/status Executive Vice Chairman
--- --------------------- ------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -----------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- -----------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 15 May 2017
under the 2014 Executive Incentive
Plan (EIP).
--- --------------------- ------------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 30,000
--- --------------------- ------------------------------------
d) Aggregated N/A
information
--- --------------------- ------------------------------------
e) Date of the 15 May 2017
transaction
--- --------------------- ------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- ------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSGDUIBBBGRU
(END) Dow Jones Newswires
May 15, 2017 10:30 ET (14:30 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024